Election to the Supervisory Board of MEDICLIN Aktiengesellschaft

Offenburg, May 28, 2015. In the context of the ordinary Annual General Meeting of MEDICLIN Aktiengesellschaft the shareholder representatives of the Supervisory Board were elected today in Frankfurt am Main. The Supervisory Board of MEDICLIN Aktiengesellschaft is composed of six employee representatives of and six shareholder representatives.

Elected to the Supervisory Board were Dr. Ulrich Wandschneider, Managing Director of Asklepios Kliniken Gesellschaft mit beschränkter Haftung and Chairman of the Corporate Management of the Asklepios Group, Michael Bock, Managing Director of REALKAPITAL Vermögensmanagement GmbH, Dr. Bernard große Broermann, entrepreneur and lawyer, Irmtraut Gürkan, Business Director and Vice Chairwoman of Universitätsklinikum Heidelberg, Rainer Laufs, Independent Business Consultant, Stephan Leonhard, Managing Director of Asklepios Kliniken Gesellschaft mit beschränkter Haftung and Vice Chairman of the Corporate Management of the Asklepios Group.

Dr. Ulrich Wandschneider was elected Chairman of the Supervisory Board in the Supervisory Board Meeting which took place after the Annual General Meeting.

About MediClin AG (Ticker: MED; WKN: 659 510) 

MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,900 employees. 

MediClin ─ a company of the Asklepios Group.